超过80%的晚期卵巢癌患者因复发需要接受二线化疗。
More than 80% of patients with advanced ovarian cancer need second-line chemotherapy for the recurrence.
目的探讨化疗联合放疗综合治疗晚期卵巢癌的疗效和毒性。
Objective: To study the effect and side effect of advanced ovarian cancer treated by chemotherapy combined with radiotherapy.
前言：目的探讨应用化疗结合热疗治疗晚期卵巢癌的护理。
Objectives:To investigate the nursing of patients with advanced ovarian carcinoma treated by chemotherapy combined with hyperthermia.
它也可以用来减少因治疗晚期卵巢癌，重复使用顺铂而累积的肾毒性。
It also may be used to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
目的观察化瘀丸联合TC方案化疗对晚期卵巢癌的疗效及化疗毒副反应。
Objective To observe clinical effects and side reactions of Huayu pill combined with TC (Paclitaxel+Carboplatin) chemotherapeutic regimes on treating epithelial ovarian cancer.
结论TPC化疗方案治疗晚期卵巢癌的效果满意，毒性反应轻，耐受性好。
Conclusion TPC chemotherapy has an excellent therapeutic effect on advanced ovarian cancer, toxicity is slight, patients' tolerance is good.
结论综合疗法能明显提高上皮型中晚期卵巢癌治疗的总有效率，延长生存期。
Conclusion This therapy can apparently increase the total efficiency for treating advanced epithelium ovarian and prolong the length of survival.
三年前，库尼被诊断出得了晚期卵巢癌。她因为工作的原因，知道主动要求接受姑息疗法。
Because of her work, Cooney knew to ask for palliative care when she was diagnosed with advanced ovarian cancer nearly three years ago.
目的为了探讨综合疗法对上皮型中晚期卵巢癌的疗效、免疫功能及生存期的影响。
Objective To study the effects of combined therapy on immune function and survival for advanced epithelium ovarian carcinoma.
新辅助化疗结合间隔手术作为晚期卵巢癌患者的替代治疗方案具有较好的应用前景。
As a promising alternative to standard primary surgery, neoadjuvant chemotherapy followed by interval surgical debulking is likely to be applicable in practice.
在晚期卵巢癌中评价以铂类药物为基础的新型治疗方案：妇科肿瘤研究团队II I期临床试验。
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic cancer Intergroup.
目的：为了提高血清CA125在晚期卵巢癌诊断中的价值，探讨分析晚期卵巢癌患者血清CA125水平的影响因素。
Objective to elevate the diagnostic value of serum CA125 in patients with advanced ovarian cancer, we analysis factors influencing the level of serum CA125.
卵巢癌通常发现时已是晚期了。
方法回顾分析1986年1月至1997年12月我院收治的以急腹症作为首发症状的晚期上皮性卵巢癌12例。
Methods 12 patients with advanced epithelial ovarian cancer presenting with abdominal emergency in cancer hospital of SMU from Jan. 1986 to Dec. 1997 were retrospectively reviewed.
卵巢癌通常在晚期才会被发现，多已经很少能治愈了，现在有一些研究建议了一些早期的警示信号。
While ovarian cancer is typically detected in its late stages, when it is least curable, several studies have now suggested that there are some early warning signs.
这篇论文表明肿瘤中高表达的IL - 8与卵巢癌患者晚期肿瘤和早期死亡相关联。
The paper demonstrates that high IL-8 expression in tumors is associated with advanced tumor stage and earlier death for ovarian cancer patients.
卵巢癌是最致命的恶性肿瘤之一，部分原因就是因为它常缺乏任何症状，等到被诊断的时候常常已经都是晚期。
Ovarian cancer is one of the most deadly cancers, in part because the symptoms are so vague that women often are not diagnosed until it is too late.
结论理想的肿瘤细胞减灭术对晚期及复发卵巢癌是安全可行的。
Conclusions Maximum cytoreductive surgery is feasible and effective for advanced and recurrent ovarian cancer.
探讨晚期和复发的上皮性卵巢癌减瘤术中脾脏切除术的必要性和可行性。
To investigate feasibility and necessity of splenectomy for tumor cytoreduction in advance or recurrent epithelial ovarian carcinoma.
卵巢癌是死亡率最高的一种疾病，其癌变早期毫无症状，一旦有临床症状时，往往已到晚期，所以其危险度不可小视。
Ovarian cancer is the highest mortality rates a kind of disease, the cancerous early symptoms, once there is no clinical symptoms, often has to late, so its risk can not be ignored.
[目的]探讨晚期和复发的上皮性卵巢癌减瘤术中脾脏切除术的必要性和可行性。
[Purpose] to investigate feasibility and necessity of splenectomy for tumor cytoreduction in advance or recurrent epithelial ovarian carcinoma.
[目的]探讨晚期和复发的上皮性卵巢癌减瘤术中脾脏切除术的必要性和可行性。
[Purpose] to investigate feasibility and necessity of splenectomy for tumor cytoreduction in advance or recurrent epithelial ovarian carcinoma.
应用推荐